The private investment firm representing Bill
Rutter and his foundation, Synergenics operates a consortium of commonly-owned yet independently managed biotech companies
Our Approach
The Synergenics consortium enables an innovative and cost-effective platform for life sciences start-ups, accelerating early stage development while preserving scientific autonomy.
They Synergenics consortium enables an innovative and cost-effective platform for life sciences start-ups, accelerating early stage development while preserving scientific autonomy.
Originally founded and run by Bill Rutter, Synergenics is now professionally managed by a team of industry leaders and experts in bringing novel biotech and healthcare innovations to market.
